Exact Sciences
EXAS
#1544
Rank
A$17.56 B
Marketcap
$94.90
Share price
5.86%
Change (1 day)
-12.20%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Net assets

Net assets on the balance sheet as of September 2024 : A$5.12 Billion

According to Exact Sciences's latest financial reports the company has A$5.12 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Exact Sciences - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$A$4.61 B3.24%
2022-12-31$A$4.47 B-4.3%
2021-12-31$A$4.67 B60.72%
2020-12-31$A$2.90 B-11.04%
2019-12-31$A$3.26 B238.09%
2018-12-31$A$0.96 B45%
2017-12-31$A$0.66 B43.31%
2016-12-31$A$0.46 B3.67%
2015-12-31$A$0.44 B27.06%
2014-12-31$A$0.35 B132.76%
2013-12-31$A$0.15 B59.9%
2012-12-31$A$94.87 M16.51%
2011-12-31$A$81.43 M3.71%
2010-12-31$A$78.51 M1057.39%
2009-12-31$A$6.78 M-296.72%
2008-12-31$-A$3.45 Million-147.95%
2007-12-31$A$7.19 M-62.1%
2006-12-31$A$18.97 M-43.61%
2005-12-31$A$33.64 M-31.44%
2004-12-31$A$49.08 M198.36%
2003-12-31$A$16.45 M-75.83%
2002-12-31$A$68.06 M-41.09%
2001-12-31$A$0.11 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
A$1.16 B-77.21%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.87 B-63.37%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.46 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
A$125.01 B 2,337.36%๐Ÿ‡ซ๐Ÿ‡ท France